Intracellular steroid activation through the STS pathway is involved in estrogen-dependent epithelial cancers, such as breast and endometrial carcinomas [10], and single nucleotide polymorphisms in SULT1E1 lead to increased risk of breast [11] and endometrial [12] cancers, together with reduced survival. This evidence concerns the gene STS and cancer.